SEC Form 4 · accession 0001487371-18-000095
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Stier
Officer — SVP & General Counsel
Period of report
May 11, 2018
Accepted (ET)
May 14, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 11, 2018 | S | 10,000 | $6.92 | D | 187,173 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person in March 2018.
- F2The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.81 to $7.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.